Top 50 Ai Diagnostics in Latin America

Onward Assist is a predictive analytics platform that utilizes AI-driven image analysis to enhance cancer diagnosis by identifying biomarkers and reducing reporting time by 30-40%. The platform addresses the lack of effective cancer scoring tools tailored for diverse populations, enabling pathologists to make more accurate treatment decisions efficiently.

PROSPERiA utilizes artificial intelligence to automatically analyze retinal images, providing personalized recommendations to prevent blindness caused by chronic diseases. The platform enhances early detection and treatment accessibility, addressing the critical issue of late diagnosis in diabetic patients.

Salva Health develops a portable screening device that utilizes artificial intelligence to detect breast abnormalities, providing women in remote areas with access to early cancer detection. This technology addresses the lack of affordable and safe screening options, aiming to reduce breast cancer mortality rates globally.

Exo develops handheld ultrasound devices integrated with artificial intelligence for imaging and therapeutic applications in medical settings. These devices enhance diagnostic accuracy and treatment efficiency, addressing the need for portable and user-friendly imaging solutions in healthcare.

Onc.AI develops an AI-powered clinical management platform that utilizes a comprehensive oncology real-world dataset, including diagnostic imaging and genomics, to enhance treatment decision-making for metastatic lung cancer patients undergoing PD-1 immunotherapy. The platform provides actionable insights that enable oncologists to improve patient outcomes by optimizing treatment strategies based on real-world evidence.

The startup develops an artificial intelligence-based respiratory health monitoring system that analyzes individual and population-level respiratory data to track disease progression and treatment outcomes. This technology enables healthcare providers to implement timely interventions for patients with respiratory illnesses, improving overall care quality.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

Longevity Medical Institute offers advanced regenerative therapies and integrated diagnostics to improve healthspan and vitality. They provide personalized treatment protocols using stem cell and exosome therapies, alongside AI-enhanced imaging and comprehensive laboratory analysis for age-related and chronic conditions.

The startup offers a vehicle service platform that utilizes diagnostic algorithms to identify and predict mechanical failures, while recommending necessary component replacements. This technology enables car service centers to lower repair costs and improve turnaround times by streamlining parts procurement processes.

Munai develops AI algorithms for hospitals and insurance providers to enhance patient management and reduce healthcare costs. Their platform enables efficient patient monitoring and data analysis, leading to improved clinical decision-making and significant cost savings.

metaBIX Biotech has developed a platform that utilizes hardware, biotechnology, and artificial intelligence to monitor airborne pathogens, providing early warnings of potential disease outbreaks in plants, animals, and humans. This technology enables clients to implement preventive measures at least two weeks before an outbreak occurs, enhancing safety and public health.

Sofya is a clinical reasoning platform that utilizes explainable AI to automate routine tasks and support complex clinical decision-making, integrating seamlessly with electronic health records. By enhancing efficiency and personalization in patient care, Sofya addresses the overwhelming administrative burden on healthcare professionals, reducing the time spent on digital paperwork and minimizing medical errors.

Eyecare Health develops advanced diagnostic tools and software solutions for ophthalmology, focusing on improving the accuracy of eye disease detection and treatment planning. The company addresses the challenges of timely and precise diagnosis in eye care, enhancing patient outcomes through data-driven insights.

The startup develops a health technology that provides personalized digital therapy and real-time health data analysis using artificial intelligence algorithms and automated devices. This technology enables chronically ill patients to manage their blood pressure, weight, and glycated hemoglobin levels through tailored physical activity programs, nutritional support, and regular monitoring.

Selector offers an AIOps platform that utilizes AI and machine learning to provide real-time incident detection and automated remediation across network and infrastructure environments. By correlating data from various sources, Selector reduces downtime and enhances operational efficiency for large-scale networks.

CLARA Analytics offers CLARAty.ai, an AI-driven Claims Intelligence Platform that utilizes Document Intelligence to analyze claims documents and medical records, providing actionable insights for risk professionals and adjusters. The platform addresses high loss costs and claim expenses by optimizing claims management processes and reducing the time required for medical cost projections and fraud detection.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

Arvo is a healthcare technology platform that utilizes artificial intelligence and machine learning to detect complex patterns and anomalies in healthcare transactions, preventing fraud, errors, and waste. By processing over R$100 billion in claims data, Arvo enhances operational efficiency and ensures compliance, saving the healthcare industry billions lost to improper reimbursements.

VivaWell provides a digital health and wellness platform that uses AI and data science to deliver personalized health programs and quality healthcare. It helps individuals and organizations improve health outcomes and manage healthcare costs through tailored services and population health insights.

Axenya is a digital health platform that utilizes real-time data analytics and AI-driven insights to monitor employee health and optimize corporate health insurance plans. By proactively identifying health risks and personalizing benefits, Axenya reduces healthcare costs for businesses while improving employee well-being.

Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.

The startup develops an AI-driven health tech software that enhances patient-clinic interactions through personalized and secure communication. This solution improves patient engagement and adherence to treatment, leading to better health outcomes in healthcare settings.

Serena offers an AI-enabled platform that monitors lifestyle factors to identify early signs of chronic diseases, enabling proactive health management for individuals, employers, and healthcare providers. By providing actionable insights, Serena helps reduce healthcare costs and improve overall well-being through targeted interventions in nutrition, physical activity, and mental health.

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.

Vitazi provides a turnkey teleretinal solution, Vitazi-MD™, that enables primary care physicians and endocrinologists to conduct diabetic retinopathy screenings without the need for retinal dilation or specialized training, facilitating quick evaluations in under two minutes. Their AI-driven system, Vitazi-DR™, autonomously analyzes scans in real-time, addressing the significant gap in diabetic retinopathy screening and helping to prevent vision loss in diabetic patients.

PRORADIS provides integrated health diagnostic solutions, including RIS, PACS, and LIS management, to streamline operations for diagnostic centers and laboratories. Their platform enhances efficiency and diagnostic accuracy through features like a unified telerradiology interface and AI-assisted analysis.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

Yeda Health utilizes artificial intelligence to provide personalized dietary and lifestyle recommendations based on individual responses to food and continuous glucose monitoring data. This approach addresses the challenge of managing blood glucose levels by recognizing that each person's metabolic response is unique, enabling tailored strategies for metabolic stability.

Invitrall develops novel in vitro diagnostic tests for infectious diseases, focusing on rapid and accurate detection. Their technology aims to improve patient outcomes by enabling earlier diagnosis and more effective treatment strategies.

Chex.ai offers a mobile platform that utilizes AI for vehicle damage detection through smartphone photos, enabling real-time identification of dents, scratches, and body defects. This solution streamlines the vehicle inspection process for the mobility industry, enhancing operational efficiency and reducing costs associated with traditional inspection methods.

Blue AI is a no-code AI platform that utilizes machine learning models, primarily XGBoost and natural language processing, to analyze health claims data for employers and healthcare providers in Latin America. It identifies potential fraud, unnecessary procedures, and predicts avoidable hospitalizations, enabling businesses to proactively manage healthcare costs and improve patient care efficiency.

The startup offers a healthcare platform that utilizes artificial intelligence and data mining to enhance treatment management for patients and medical providers. By enabling patients to identify specialists and appropriate treatments, the platform improves diagnostic analysis and user experience, ultimately reducing the time and resources required for patient care.

Pix Force utilizes computer vision and artificial intelligence to automate visual inspections, enhancing efficiency and accuracy in industrial processes. The technology addresses the challenges of time-consuming and error-prone manual inspections, significantly reducing operational risks and improving productivity.

See Me is a B2B platform that utilizes an ANVISA-approved self-collection device and PCR analysis for less invasive gynecological diagnostics, focusing on the evaluation of vaginal microbiome, STIs, HPV, and recurrent vulvovaginitis. The platform streamlines patient navigation and automates therapeutic plans, enabling gynecologists to provide precise diagnoses and tailored treatments more efficiently.

Vennx offers integrated Governance, Risk, and Compliance (GRC) solutions powered by AI to help organizations manage complex regulatory environments. Their platform automates GRC functions, provides real-time access monitoring, and delivers AI-driven diagnostics to enhance security, ensure compliance, and mitigate risks.

This healthcare platform uses AI to analyze a patient's complete medical history, including medications and exam results, to generate intelligent diagnostic hypotheses. It helps medical professionals formulate accurate diagnoses by feeding patient characteristics into an algorithm, streamlining the diagnostic process.

AIMedic utilizes artificial intelligence to integrate diverse medical data sources, enhancing diagnostic accuracy and treatment selection for healthcare professionals. The platform supports patient monitoring through an intelligent assistant, providing validated educational resources and vital health updates to improve patient outcomes.

Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.

ZophIA utilizes artificial intelligence and geometric analysis of patient speech to enhance the diagnosis of mental disorders, particularly schizophrenia, achieving 99% accuracy in pilot tests. The tool addresses the urgent need for timely and accurate mental health assessments, alleviating the burden on healthcare professionals amid rising demand for mental health services.

The startup develops a blood collection device that enables users to self-collect samples and send them for analysis. Utilizing dried plasma separation technology and medical algorithms, the company provides accurate health risk assessments based on individual health data, family history, and lifestyle factors.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

The startup develops an anti-sleep headband that utilizes high-fidelity EEG technology and AI to detect drowsiness and microsleep in real-time. This device enhances driver safety by activating alert mechanisms to prevent accidents caused by fatigue.

Axiom Tech offers integrated solutions for corporate health and wellness, legal case management, and clinical decision support. Their platform enhances employee well-being, streamlines health-related litigation, and provides AI-powered assistance for medical teams to improve patient care.

Scout has developed a nucleic acid testing platform that utilizes patented technology to deliver lab-grade diagnostic tests at home, schools, and offices with results available in 30 minutes. This system addresses the inaccessibility and low accuracy of traditional home health tests by providing a more sensitive and accurate alternative, achieving 99% accuracy compared to lab tests.

Pitts Crew is a mobile application that connects vehicle owners with reliable car repair and maintenance services through real-time diagnostics using AI-assisted communication. The platform allows users to describe vehicle issues via voice or video, enabling experts to provide immediate solutions, estimated costs, and service availability.

PEGASI leverages data analytics to optimize the diagnostic and treatment workflow for cancer patients in Latin America, significantly reducing the time from initial suspicion to treatment initiation. By providing real-time visibility and structured data management throughout the patient journey, the platform enhances care coordination and improves patient outcomes.

TELL Toolkit utilizes AI-driven analysis of natural speech patterns to provide objective metrics for early detection of brain disorders and neurocognitive decline. This technology offers real-time insights for clinical and educational settings, enhancing assessments of language development and cognitive health.

NeuroGeneces offers the NeuroInsight™ assessment, which utilizes biometric sensors and AI algorithms to detect atypical brain decline up to two decades before symptoms appear, enabling timely intervention. Additionally, the NeuroGevity system enhances memory consolidation by stimulating slow-wave sleep through synchronized sound, improving brain activity related to memory preservation.